ALT logo

Altimmune (ALT) Current Liabilities

Annual Current Liabilities

$12.14 M
-$4.91 M-28.80%

December 31, 2023

Summary

Performance

1-Year Change

-28.8%

3-Year Change

+1.02%

5-Year Change

+168.21%

15-Year Change

+216.25%

ALT Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

35.38%
ALT annual total current liabilities is higher than 35.38% of companies in Healthcare sector

High & Low

All-time High

$35.87 M
ALT annual total current liabilities is currently -66.15% below its historical high of $35.87 million

3-Year Low

$12.14 M
ALT annual total current liabilities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ALT previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 27, 2025
ALT next annual earnings announcement is scheduled for Mar 27, 2025

OtherALTbalance sheetmetrics:

Annual Total Liabilities

$16.54 M
ALT annual total liabilities is $16.54 million

Annual Total Long Term Liabilities

$4.40 M
ALT annual total long term liabilities is $4.40 million

Annual Total Assets

$210.64 M
ALT annual total assets is $210.64 million

Annual Current Assets

$209.63 M
ALT annual total current assets is $209.63 million

Quarterly Current Liabilities

$8.64 M
-$6.52 M-43.00%

September 30, 2024

Summary

Performance

3-Month Change

-43%

1-Year Change

-28.86%

3-Year Change

-54.84%

5-Year Change

+250.17%

ALT Quarterly Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

27.76%
ALT quarterly total current liabilities is higher than 27.76% of companies in Healthcare sector

High & Low

All-time High

$35.87 M
ALT quarterly total current liabilities is currently -75.92% below its historical high of $35.87 million

3-Year Low

$8.64 M
ALT quarterly total current liabilities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ALT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 27, 2025
ALT next earnings announcement is scheduled for Mar 27, 2025

OtherALTbalance sheetmetrics:

Quarterly Total Liabilities

$14.49 M
ALT quarterly total liabilities is $14.49 million

Quarterly Long Term Liabilities

$5.85 M
ALT quarterly total long term liabilities is $5.85 million

Quarterly Total Assets

$147.86 M
ALT quarterly total assets is $147.86 million

Quarterly Current Assets

$145.76 M
ALT quarterly total current assets is $145.76 million

Current Liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

Annual Current Liabilities

$12.14 M
ALT annual total current liabilities is $12.14 million

Annual Accounts Payable

$2.07 M
ALT annual accounts payable is $2.07 million

Annual Short Term Debt

$496.00 K
ALT annual short term debt is $496.00 thousand

ALT Current Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-28.8%-28.9%
3 y3 years+1.0%-54.8%
5 y5 years+168.2%+250.2%

ALT Current Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-33.6%at low-54.8%at low
5 y5-year-33.6%+209.5%-54.8%+120.2%
alltimeall time-66.2%+2858.1%-75.9%+4723.0%

Altimmune Current Liabilities History

DateAnnualQuarterly
Sep 2024
-
$8.64 M(-43.0%)
Jun 2024
-
$15.15 M(+33.7%)
Mar 2024
-
$11.33 M(-6.7%)
Dec 2023
$12.14 M(-28.8%)
$12.14 M(+2.3%)
Sep 2023
-
$11.87 M(+3.8%)
Jun 2023
-
$11.44 M(-23.5%)
Mar 2023
-
$14.95 M(-12.3%)
Dec 2022
$17.05 M(-6.7%)
$17.05 M(+8.3%)
Sep 2022
-
$15.74 M(+13.7%)
Jun 2022
-
$13.85 M(-27.6%)
Mar 2022
-
$19.12 M(+4.6%)
Dec 2021
$18.28 M(+52.0%)
$18.28 M(-4.4%)
Sep 2021
-
$19.13 M(+110.3%)
Jun 2021
-
$9.10 M(-7.4%)
Mar 2021
-
$9.82 M(-18.3%)
Dec 2020
$12.02 M(+206.4%)
$12.02 M(+91.0%)
Sep 2020
-
$6.29 M(+28.0%)
Jun 2020
-
$4.92 M(-18.7%)
Mar 2020
-
$6.05 M(+54.1%)
Dec 2019
$3.92 M(-13.3%)
$3.92 M(+59.0%)
Sep 2019
-
$2.47 M(-29.1%)
Jun 2019
-
$3.48 M(-5.3%)
Mar 2019
-
$3.68 M(-18.8%)
Dec 2018
$4.53 M(+17.9%)
$4.53 M(-45.7%)
Sep 2018
-
$8.34 M(+18.1%)
Jun 2018
-
$7.07 M(+37.1%)
Mar 2018
-
$5.16 M(+34.3%)
Dec 2017
$3.84 M(-29.8%)
$3.84 M(-8.2%)
Sep 2017
-
$4.18 M(-24.4%)
Jun 2017
-
$5.53 M(+147.4%)
Mar 2017
-
$2.23 M(-59.2%)
Dec 2016
$5.47 M(+151.0%)
$5.47 M(+46.7%)
Sep 2016
-
$3.73 M(+14.1%)
Jun 2016
-
$3.27 M(+23.8%)
Mar 2016
-
$2.64 M(+21.1%)
Dec 2015
$2.18 M
$2.18 M(-8.5%)
Sep 2015
-
$2.38 M(-28.6%)
Jun 2015
-
$3.34 M(-26.5%)
DateAnnualQuarterly
Mar 2015
-
$4.54 M(+75.7%)
Dec 2014
$2.58 M(-62.0%)
$2.58 M(-33.5%)
Sep 2014
-
$3.88 M(+37.2%)
Jun 2014
-
$2.83 M(-18.3%)
Mar 2014
-
$3.47 M(-49.0%)
Dec 2013
$6.80 M(-9.2%)
$6.80 M(+25.5%)
Sep 2013
-
$5.41 M(-29.9%)
Jun 2013
-
$7.72 M(-0.8%)
Mar 2013
-
$7.79 M(+4.0%)
Dec 2012
$7.49 M(+62.3%)
$7.49 M(+7.4%)
Sep 2012
-
$6.97 M(+23.2%)
Jun 2012
-
$5.66 M(+6.5%)
Mar 2012
-
$5.31 M(+15.1%)
Dec 2011
$4.62 M(-25.1%)
$4.62 M(+25.0%)
Sep 2011
-
$3.69 M(-37.7%)
Jun 2011
-
$5.93 M(-11.5%)
Mar 2011
-
$6.70 M(+8.7%)
Dec 2010
$6.16 M(-54.2%)
$6.16 M(-79.5%)
Sep 2010
-
$30.03 M(+136.7%)
Jun 2010
-
$12.69 M(-11.7%)
Mar 2010
-
$14.38 M(+6.8%)
Dec 2009
$13.47 M(-62.5%)
$13.47 M(-17.5%)
Sep 2009
-
$16.33 M(-47.7%)
Jun 2009
-
$31.22 M(-7.5%)
Mar 2009
-
$33.76 M(-5.9%)
Dec 2008
$35.87 M(+298.7%)
$35.87 M(+21.9%)
Sep 2008
-
$29.44 M(+90.9%)
Jun 2008
-
$15.42 M(+58.4%)
Mar 2008
-
$9.73 M(+8.2%)
Dec 2007
$9.00 M(-36.6%)
$9.00 M(-16.8%)
Sep 2007
-
$10.81 M(+705.9%)
Mar 2007
-
$1.34 M(-90.5%)
Dec 2006
$14.19 M(+3357.8%)
$14.19 M(+1933.8%)
Sep 2006
-
$697.90 K(+21.2%)
Jun 2006
-
$575.90 K(-6.6%)
Mar 2006
-
$616.70 K(+50.2%)
Dec 2005
$410.50 K
$410.50 K(+129.2%)
Sep 2005
-
$179.10 K(-0.2%)
Jun 2005
-
$179.50 K

FAQ

  • What is Altimmune annual total current liabilities?
  • What is the all time high annual current liabilities for Altimmune?
  • What is Altimmune annual current liabilities year-on-year change?
  • What is Altimmune quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Altimmune?
  • What is Altimmune quarterly current liabilities year-on-year change?

What is Altimmune annual total current liabilities?

The current annual current liabilities of ALT is $12.14 M

What is the all time high annual current liabilities for Altimmune?

Altimmune all-time high annual total current liabilities is $35.87 M

What is Altimmune annual current liabilities year-on-year change?

Over the past year, ALT annual total current liabilities has changed by -$4.91 M (-28.80%)

What is Altimmune quarterly total current liabilities?

The current quarterly current liabilities of ALT is $8.64 M

What is the all time high quarterly current liabilities for Altimmune?

Altimmune all-time high quarterly total current liabilities is $35.87 M

What is Altimmune quarterly current liabilities year-on-year change?

Over the past year, ALT quarterly total current liabilities has changed by -$3.50 M (-28.86%)